Navigation Links
Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241,in Patients With Advanced Solid Tumors

vely kills cisplatin-resistant cells when used as monotherapy, and restores cisplatin sensitivity. Cisplatin is one of the most commonly utilized treatments for lung, breast and colon cancers. However, development of cisplatin resistance is a common event and the ability of INGN 241 to kill these resistant tumors and restore cisplatin efficacy has important clinical implications. Previous INGN 241 preclinical studies have indicated similar synergies with other chemotherapies and with radiation treatment.

Dr. Chada added, "These preclinical data demonstrate that INGN 241 can restore sensitivity to cisplatin, a widely used chemotherapy drug that frequently gives rise to resistance. Our findings support applications of INGN 241 in combination with standard chemotherapy and radiation regimens and we are planning future clinical trials based on these results."

About INGN 241

INGN 241 is being tested in a Phase 2 clinical trial for patients suffering from advanced melanoma and in a Phase 3 clinical trial in combination with radiation therapy in solid tumors. The mda-7 gene is the active component of INGN 241 and was discovered in the laboratory of Dr. Paul B. Fisher, professor of clinical pathology at Columbia University. Introgen holds an exclusive worldwide sublicense to the Columbia University rights for all gene therapy applications from GlaxoSmithKline.

About Introgen

Introgen Therapeutics, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. Introgen is developing molecular therapeutics, immunotherapies, vaccines and nano-particle tumor suppressor therapies to treat a wide range of cancers using tumor suppressors, cytokines and genes. Introgen maintains integrated research, development, manufacturing, clinical and regulatory departments and operates multiple manufacturing facilities including a commercial scale
'"/>




Page: 1 2 3

Related medicine technology :

1. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
2. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
3. Introgen and Clinical Collaborators to Report New Results with Advanced-Stage Cancer Therapies at Upcoming Medical Meetings
4. Preclinical Studies Identify Novel Approach for Enhancing the Anticancer Activity of Introgens INGN 241
5. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
6. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
7. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
10. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
11. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
Post Your Comments:
(Date:10/31/2014)... , Oct. 31, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ...  What: , Isis Pharmaceuticals, Third Quarter 2014 ... November 7 at 11:30 a.m. ET / 8:30 a.m. ... on the Internet. Simply log onto our website listed ... live event, a replay of the webcast will be ...
(Date:10/30/2014)... , Oct. 30, 2014  Misonix, Inc. (NASDAQ: ... company that designs, manufactures and markets innovative therapeutic ultrasonic ... announced today that it will report financial results for ... 6, 2014. The Company has scheduled a conference call ... pm ET to review the results. ...
(Date:10/30/2014)... Oct. 30, 2014  Zimmer Holdings, Inc. (NYSE: ... future executive leadership team and organizational structure of the ... Zimmer also announced that the combined organization will leverage ... named Zimmer Biomet, with the new brand to be ... of the merger.  The future leadership team is committed ...
Breaking Medicine Technology:Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Third Quarter 2014 Financial Results Conference Call 3Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9
... Resource, Inc. (OTCBB: CHRI), announced today that world renowned ... engaged to lead the Company,s Gastrodia Deep Processing Research. ... raw Gastrodia and to find new potential uses of ... age 73, is currently a member of the State ...
...   Vocollect Healthcare Systems , part of Vocollect, a business ... ), announces that the Homestead of Sherman has ... Homestead of Sherman to deliver quality care to ... , AccuNurse interactive care enables Sherman,s ...
Cached Medicine Technology:China Health Resource Announces Professor Liang Li, World Renowned TCM Expert, to Lead Gastrodia Deep Processing Research 2China Health Resource Announces Professor Liang Li, World Renowned TCM Expert, to Lead Gastrodia Deep Processing Research 3Homestead of Sherman Uses AccuNurse Interactive Care to Improve Care and Service 2Homestead of Sherman Uses AccuNurse Interactive Care to Improve Care and Service 3
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Surgery for low ... where in the United States you live, a new ... experience low back pain at some point in their ... professional medical care for a spine problem," co-author Brook ... Clinical Practice, said in a college news release. ...
(Date:10/31/2014)... In terms of duration of treatment and cost, ... from accelerated partial breast irradiation (APBI) with proton ... new research from The University of Texas MD ... a cost analysis study based on typical patient ... allowable charges for eight different types of partial ...
(Date:10/31/2014)... a lab device to give cancer researchers an unprecedented ... cells spread through the body, causing more than 90 ... how tumor cells travel, the device could uncover new ... from the university,s Whiting School of Engineering and its ... their new system recently in the journal Cancer ...
(Date:10/31/2014)... New York (PRWEB) October 31, 2014 ... Mineola Eye in Garden City, Long Island and the ... to their medical staff, according to North Shore Eye ... is the Emeritus Acting Chairman of the Department of ... and successful practice in Garden City for more than ...
(Date:10/31/2014)... October 31, 2014 Florida Air ... and girls in grades 6-12, is taking the ... sports injuries and concussions, becoming the first high ... ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) computerized ... NFL Player' lawsuit grabs the headlines, and the ...
Breaking Medicine News(10 mins):Health News:Spinal Surgery Varies by Region in U.S.: Study 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3Health News:Viewing cancer on the move: New device yields close-up look at metastasis 2Health News:Viewing cancer on the move: New device yields close-up look at metastasis 3Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 2Health News:William Kasper, MD Garden City Ophthalmologist, Joins Medical Staff at North Shore Eye Care 3Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3
... Autopsies of quick-witted elderly hint at how they stayed that ... the brains of elderly people may help explain why some ... people who maintain sharp mental focus and ability well into ... that the brains of these still-sharp folks over 80 have ...
... This release is available in French . ... one come out of this?" After an accident that results ... simple question can change everything for a family. , The ... Mitra Feyz and all the clinicians of the Traumatic Brain ...
... risk of recurrence, lengthened disease-free survival, study finds , , ... improve the chances of survival for breast cancer patients, ... mood improvement, effective coping and altering health behaviors appear ... according to the report, published in the Dec. 15 ...
... tracking the business of robotics. , ... Santa Barbara, CA (PRWEB) November ... website dedicated to tracking the business of robotics. It is a ... , , ,   • Service Robots for Governmental and Corporate Use ,   • Service ...
... of HealthCare Partners LLC, a healthcare provider with operations in California, ... the Legacy Society of the California Hospital Medical Center Foundation as ... understanding of the dynamics of the healthcare marketplace. , ... ...
... given a choice between viewing pictures of cocaine and ... compared to healthy, non-addicted research subjects, show a clear ... which was conducted at the U.S. Department of Energy,s ... Society for Neuroscience annual meeting in Washington D.C. on ...
Cached Medicine News:Health News:Fewer Brain 'Tangles' May Mean Smarter Old Age 2Health News:Fewer Brain 'Tangles' May Mean Smarter Old Age 3Health News:Predicting the future for patients with severe traumatic brain injury 2Health News:Psychological Counseling Boosts Breast Cancer Outcomes 2Health News:New Website Launched, The Robot Report, Tracking The Business of Robotics 2Health News:Healthcare Provider, HealthCare Partners, CEO Dr. Robert Margolis Honored for Hospital Philanthropy 2Health News:Healthcare Provider, HealthCare Partners, CEO Dr. Robert Margolis Honored for Hospital Philanthropy 3Health News:Healthcare Provider, HealthCare Partners, CEO Dr. Robert Margolis Honored for Hospital Philanthropy 4Health News:Drug-related preference in cocaine addiction extends to images 2
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... Splint uses safe, mild to moderate force ... at the MP joints. Dorsal-based splint does ... ulnar polycentric hinges located at the MP ... malleable finger rings can be individually shaped ...
... RCAI Dorsal Blocking Splint is constructed of a ... DBS protects the flexor tendons of the hand ... scar tissue development in the later stages of ... dorsally on the hand and positions the wrist ...
Bunell Mini-Modified Safety Finger Pin reduces PIP flexion contractures....
Medicine Products: